NRx (New Prescription)
NRx, or New Prescription, is a pharmaceutical sales metric counting prescriptions written for the first time within a measurement period, as opposed to refills. Combined with total prescriptions, it helps commercial teams assess a drug's new-patient adoption and prescriber behavior.
What is NRx (New Prescription)?
NRx, short for New Prescription, is a pharmaceutical sales metric that counts prescriptions written for the first time during a defined measurement period. It separates brand-new prescribing activity from refills of existing therapy.
By focusing only on first-time prescriptions, NRx highlights fresh prescribing decisions rather than the continuation of established treatment. It is commonly reported alongside total prescription counts to give a fuller view of demand.
Why does NRx matter to commercial teams?
NRx is a useful gauge of new-patient adoption and changing prescriber behavior, since rising new prescriptions suggest a product is gaining traction. Commercial teams use it to assess momentum and to evaluate the effect of promotional and educational efforts.
Comparing NRx with total prescriptions helps distinguish genuine growth from mere persistence of existing patients. This distinction informs forecasting, territory planning, and decisions about where to direct field resources.
- what is nrx
- nrx meaning
- new prescription metric
- nrx vs trx
- nrx pharma
- nrx definition
- new prescriptions